266 related articles for article (PubMed ID: 28603527)
1. Intratumoral FoxP3
Syed Khaja AS; Toor SM; El Salhat H; Ali BR; Elkord E
Front Immunol; 2017; 8():619. PubMed ID: 28603527
[TBL] [Abstract][Full Text] [Related]
2. Correlations between Circulating and Tumor-Infiltrating CD4
Al-Mterin MA; Murshed K; Elkord E
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455287
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
Front Immunol; 2019; 10():2936. PubMed ID: 31921188
[TBL] [Abstract][Full Text] [Related]
4. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
[TBL] [Abstract][Full Text] [Related]
5. Correlations between Circulating and Tumor-Infiltrating CD4
Al-Mterin MA; Murshed K; Elkord E
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146549
[TBL] [Abstract][Full Text] [Related]
6. Associations of different immune checkpoints-expressing CD4
Al-Mterin MA; Murshed K; Alsalman A; Abu-Dayeh A; Elkord E
BMC Cancer; 2022 Jun; 22(1):601. PubMed ID: 35655158
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
[TBL] [Abstract][Full Text] [Related]
8. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
Müller M; Herrath J; Malmström V
Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
[TBL] [Abstract][Full Text] [Related]
9. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8
Alsalman A; Al-Mterin MA; Murshed K; Alloush F; Al-Shouli ST; Toor SM; Elkord E
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804964
[TBL] [Abstract][Full Text] [Related]
10. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
Toor SM; Syed Khaja AS; Alkurd I; Elkord E
Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
[TBL] [Abstract][Full Text] [Related]
11. CD39
Ahlmanner F; Sundström P; Akeus P; Eklöf J; Börjesson L; Gustavsson B; Lindskog EB; Raghavan S; Quiding-Järbrink M
Oncotarget; 2018 Dec; 9(97):36993-37007. PubMed ID: 30651930
[TBL] [Abstract][Full Text] [Related]
12. Foxp3
Liu L; Zhang Q; Chen P; Guo N; Song A; Huang X; Xia W; Li L; Moog C; Wu H; Su B; Zhang T
BMC Immunol; 2019 Oct; 20(1):38. PubMed ID: 31651258
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer.
Timperi E; Pacella I; Schinzari V; Focaccetti C; Sacco L; Farelli F; Caronna R; Del Bene G; Longo F; Ciardi A; Morelli S; Vestri AR; Chirletti P; Barnaba V; Piconese S
Oncoimmunology; 2016 Jul; 5(7):e1175800. PubMed ID: 27622025
[TBL] [Abstract][Full Text] [Related]
14. Altered frequency of CD8
Rostamzadeh D; Haghshenas MR; Daryanoosh F; Samadi M; Hosseini A; Ghaderi A; Mojtahedi Z; Babaloo Z
J Cell Physiol; 2019 Jul; 234(7):11986-11998. PubMed ID: 30623416
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.
Jie HB; Gildener-Leapman N; Li J; Srivastava RM; Gibson SP; Whiteside TL; Ferris RL
Br J Cancer; 2013 Nov; 109(10):2629-35. PubMed ID: 24169351
[TBL] [Abstract][Full Text] [Related]
16. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
Lord JD; Shows DM; Chen J; Thirlby RC
PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
[TBL] [Abstract][Full Text] [Related]
17. Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans.
Himmel ME; MacDonald KG; Garcia RV; Steiner TS; Levings MK
J Immunol; 2013 Mar; 190(5):2001-8. PubMed ID: 23359504
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
Sasidharan Nair V; Elkord E
Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
[TBL] [Abstract][Full Text] [Related]
19. Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells.
Yates K; Bi K; Haining WN; Cantor H; Kim HJ
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2162-2167. PubMed ID: 29440380
[TBL] [Abstract][Full Text] [Related]
20. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]